INTAS PHARMS LTD FDA Approval ANDA 214036

ANDA 214036

INTAS PHARMS LTD

FDA Drug Application

Application #214036

Application Sponsors

ANDA 214036INTAS PHARMS LTD

Marketing Status

None (Tentative Approval)001
None (Tentative Approval)002

FDA Submissions

UNKNOWN; ORIG1TA2022-10-13STANDARD

Submissions Property Types

ORIG1Null31

CDER Filings

INTAS PHARMS LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 214036
            [companyName] => INTAS PHARMS LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"TRIFLURIDINE; TIPIRACIL","activeIngredients":"TRIFLURIDINE; TIPIRACIL","strength":"15MG\/6.14MG","dosageForm":"TABLET;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"},{"drugName":"TRIFLURIDINE; TIPIRACIL","activeIngredients":"TRIFLURIDINE; TIPIRACIL","strength":"20MG\/8.19MG","dosageForm":"TABLET;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"10\/13\/2022","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2022-10-13
        )

)

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.